epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Duopa
    carbidopa/ levodopa
  • remove Pristiq
    desvenlafaxine

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Caution Advised

Smiley face Smiley face Duopa (carbidopa/ levodopa) + Pristiq (desvenlafaxine)

Caution Advised


levodopa + desvenlafaxine

caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Additional Considerations

Smiley face Smiley face desvenlafaxine in Pristiq

add MAO inhibitor to Interaction Check if recent (14 days) use

Smiley face Smiley face levodopa in Duopa

add MAO inhibitor to Interaction Check if recent (14 days) use

avoid combo with beverages or products containing ethanol and Crexont; combo may incr. levodopa release rate, levels, risk of adverse effects, decr. duration of efficacy

Smiley face Smiley face carbidopa in Duopa

avoid combo with beverages or products containing ethanol and Crexont; combo may incr. carbidopa release rate, levels, risk of adverse effects, decr. duration of efficacy

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information